Sunmax Biotechnology Co., Ltd. (4728.TWO)
TWD 344.5
(-9.93%)
TWD 344.5
(-9.93%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.15 Billion TWD | 20.4% |
| 2022 | 1.79 Billion TWD | 20.84% |
| 2021 | 1.48 Billion TWD | 8.79% |
| 2020 | 1.36 Billion TWD | 22.6% |
| 2019 | 1.11 Billion TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.32 Billion TWD | 7.77% |
| 2024 Q2 | 2.39 Billion TWD | 2.92% |
| 2023 Q1 | 2 Billion TWD | 0.0% |
| 2023 Q4 | 2.15 Billion TWD | 10.64% |
| 2023 FY | 2.15 Billion TWD | 20.4% |
| 2023 Q3 | 1.95 Billion TWD | -15.06% |
| 2023 Q2 | 2.29 Billion TWD | 14.83% |
| 2022 FY | 1.79 Billion TWD | 20.84% |
| 2022 Q4 | - TWD | 0.0% |
| 2021 FY | 1.48 Billion TWD | 8.79% |
| 2020 FY | 1.36 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -1586.125% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 25.573% |
| Level Biotechnology Inc. | 822.67 Million TWD | -162.441% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -224.802% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -293.447% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 44.554% |
| GlycoNex Incorporation | 1.55 Billion TWD | -39.04% |
| VBI | 452.1 Million TWD | -377.554% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -83.569% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -188.42% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -470.626% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -90.417% |
| Visgeneer Inc. | 397.17 Million TWD | -443.596% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 42.737% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -144.485% |
| Neith Corporation | 192.15 Million TWD | -1023.6% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 64.563% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -2835.142% |
| Enimmune corporation | 604.82 Million TWD | -256.967% |
| TaiRx, Inc. | 833.74 Million TWD | -158.956% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 30.039% |
| EirGenix Inc. | 11.16 Billion TWD | 80.658% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -276.703% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | -26.085% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 39.972% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -105.528% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -617.21% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -715.785% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -389.364% |
| RBC Bioscience Corporation | 753.79 Million TWD | -186.424% |
| BiOptic Inc. | 613.77 Million TWD | -251.764% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | -21.385% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -86.169% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -234.812% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 30.494% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -1359.456% |
| NaviFUS Corp. | 490.53 Million TWD | -340.138% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -76.145% |
| Sinew Pharma Inc. | 1.36 Billion TWD | -58.359% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -308.022% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -85.901% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -30.354% |
| AP Biosciences Inc | 890.75 Million TWD | -142.382% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 74.681% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -566.064% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -61.89% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 20.362% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 85.947% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -426.262% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -444.041% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | -4.004% |
| TCI GENE Inc. | 1.16 Billion TWD | -85.175% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -632.916% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -58.364% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -129.255% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -209.117% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 45.395% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 43.52% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -75.554% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 61.473% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -103.297% |
| Acepodia, Inc. | 6.81 Billion TWD | 68.336% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 43.577% |